Mayo Clinic Connects with Biospecimen Collection Company for Personalized Medicine | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Mayo Clinic Connects with Biospecimen Collection Company for Personalized Medicine

September 12, 2016
by Rajiv Leventhal
| Reprints

The Mayo Clinic’s Center for Individualized Medicine and the Lexington, Mass.-based biospecimen collection company iSpecimen are collaborating for a partnership that will connect biomedical researchers with samples from Mayo’s cancer serum biobank and associated data for their studies.

The Cancer/Normal Serum Biobank, located on Mayo Clinic’s campus in Rochester, Minn., includes approximately 130,000 frozen vials of serum from about 17,000 unique, consented patients. The samples were collected between 1975 and 1990 across 85 different malignant and benign conditions. iSpecimen, which works to procure annotated samples for life science researchers, will manage the serum inventory and associated data through its cloud-based technology solution, matching researchers to the right samples to fuel their studies, according to a company press release.

“As is the case with many biorepositories, intensive resources have been put into creating a variety of sample collections along with state-of-the-art facilities,” Stephen Thibodeau, Ph.D., the David F. and Margaret T. Grohne Director, Biorepositories Program, Mayo Clinic Center for Individualized Medicine, said in a prepared statement. “But despite holding thousands of sought-after samples, the biorepository is underutilized by external researchers. iSpecimen presented an opportunity for us to work with them to efficiently move these specimens into the hands of many more scientists studying cancer and related conditions, which ultimately should result in better treatments.”

With the surge of precision medicine, and particularly increased interest and funding for cancer research, as evidenced by initiatives such as the Cancer Moonshot and Parker Institute for Cancer Immunotherapy, Mayo Clinic’s Cancer/Normal Serum Biobank has the potential to present research value not only due to the thousands of serum samples it holds, but also due to the longitudinal nature of many of the samples. “Also of considerable value is the clinical annotation accompanying the samples, which includes patient demographics, blood collection data, tumor information, treatment information, and status of tumor at time of blood collection,” the press release stated.

“Developed specifically with researchers in mind, iSpecimen is proud to collaborate with Mayo Clinic to help to expand this biobank’s reach across the scientific community,” said Christopher Ianelli, M.D., Ph.D., CEO, iSpecimen. “It’s estimated that the number of new cancer cases per year will rise from 14 to 22 million globally within the next two decades. As oncology research continues to evolve at a rapid pace, providing researchers fast access to the right, high-quality biospecimens will be crucial to helping them execute on new ways of understanding, diagnosing and treating this disease.”

Mayo Clinic has a strong history in biobanking, which is reflected in their recent funding award of $142 million over five years by the National Institutes of Health (NIH) to serve as the national Precision Medicine Initiative (PMI) Cohort Program Biobank.. This biobank will hold the research repository of biospecimens for the longitudinal program that aims to enroll one million or more U.S. participants to better understand individual differences that contribute to health and disease to advance precision medicine.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Advocate Aurora Health, Foxconn Plan Employee Wellness, “Smart City,” and Precision Medicine Collaboration

Wisconsin-based Advocate Aurora Health is partnering with Foxconn Health Technology Business Group, a Taiwanese company, to develop new technology-driven healthcare services and tools.

Healthcare Data Breach Costs Remain Highest at $408 Per Record

The cost of a data breach for healthcare organizations continues to rise, from $380 per record last year to $408 per record this year, as the healthcare industry also continues to incur the highest cost for data breaches compared to any other industry, according to a new study from IBM Security and the Ponemon Institute.

Morris Leaves ONC to Lead VA Office of Electronic Health Record Modernization

Genevieve Morris, who has been detailed to the U.S. Department of Veterans Affairs (VA) from her position as the principal deputy national coordinator for the Department of Health and Human Services, will move over full time to lead the newly establishment VA Office of Electronic Health Record Modernization.

Cedars-Sinai Accelerator Program Presents Fourth Class of Startups

The Cedars-Sinai Accelerator, a program that helps entrepreneurs bring their innovative technology products to market, has brought in nine more health tech startups as part of its fourth class.

DirectTrust Adds Five Board Members

DirectTrust, a nonprofit organization that support health information exchange, announced the appointment of five new executives to its board of directors.

Analysis: Many States Continue to Have Restrictive Telemedicine Policies

State Medicaid programs are evolving to accelerate the adoption of telemedicine models, this evolution is occurring more quickly in some states than others, according to a recent analysis by Manatt Health.